New assays: Ipamorelin, CJC-1295 (no DAC), CJC/IPA and Tesa/IPA blends, Kisspeptin, SS-31. Shop tests →
PuriLab Analytical
COA/KL-2026-004Verified
Save as PDF

Certificate of Analysis

PuriLab Analytical

KLOW 80 mg

KL-2026-004Lot 080525-A03Analyzed October 27, 2026
KLOW 80 mg vial as received

Timeline

Ordered
October 19, 2026
Received
October 22, 2026
Analyzed
October 27, 2026

Sample

Name
KLOW 80 mg
Expected
KLOW blend (GHK-Cu, BPC-157, TB-500, KPV)
Amount
1 vial, lyophilized powder

Testing

Client
Parish Innovations
Test type
Content & purity
Method
HPLC-UV
Content, how much is in it
GHK-Cu67.2mg
Label claim: 50 mg
BPC-15712.50mg
Label claim: 10 mg
TB-500Notdetected
Label claim: 10 mg
KPV11.21mg
Label claim: 10 mg
Purity, how clean it is
>99%
Peptide purity, HPLC-UV peak area

Chromatogram

HPLC-UV

mAU501001502001111.51212.51313.514Retention time (min), 10.9 to 14 min11.49
11.49 min, BPC-157, >99%

Analyst Comments

Blue lyophilized powder, black-cap vial, received sealed. GHK-Cu and KPV were measured on a second HPLC-UV method; the chromatogram shows the BPC-157 / TB-500 method. TB-500 was not detected (detection limit about 0.5 mg).

Analyst Signature

Max Barrett
Lab Director, PuriLab Analytical
Analysis date: October 27, 2026

Verification Code

KL-IF10-A0I5
Verify at purilab.org/verify/KL-IF10-A0I5

Scan to Verify

KL-IF10-A0I5

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analyticaladmin@purilab.org
Page 1 of 1